Overview

Metformin in Stage IV Lung Adenocarcinoma

Status:
Terminated

Trial end date:
2016-06-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine whether metformin is effective in lowering plasma IL-6 level and improving the treatment response in patients with non-small cell lung cancer

Phase:

Phase 2

Details

Lead Sponsor:

National Cheng-Kung University Hospital

Treatments:

Metformin